title: Is a methodology available that accurately measures the cost of an FDG-PET study?
authors.affiliation: Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium. bruno.krug@imre.ucl.ac.be.
authors.forename: Bruno
authors.initials: B
authors.lastname: Krug
authors.affiliation: Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium.
authors.forename: Anne Sophie
authors.initials: AS
authors.lastname: Pirson
authors.affiliation: Belgian Health Care Knowledge Center, Brussels, Belgium.
authors.forename: Ralph
authors.initials: R
authors.lastname: Crott
authors.affiliation: Nuclear Medicine Department, Université Catholique de Louvain, 1 Dr Thérasse, 5530, Yvoir, Belgium.
authors.forename: Thierry
authors.initials: T
authors.lastname: Vander Borght
mesh_terms: D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D003952:Diagnostic Imaging / Q000191:economics; D004470:Economics, Medical; D019788:Fluorodeoxyglucose F18; D006801:Humans; D049268:Positron-Emission Tomography / Q000191:economics* / Q000379:methods*; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18